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Morphine prevents the development of stress-enhanced fear learning
Jennifer L. Szczytkowski-Thomson, Christina L. Lebonville, Donald T. Lyslea
Abstract

The current study investigates the pharmacotherapeutic use of morphine as a preventative
treatment for stress-enhanced fear learning, an animal model that closely mimics symptoms of
post-traumatic stress disorder (PTSD). PTSD is a chronic and debilitating anxiety disorder
characterized by exaggerated fear and/or anxiety that may develop as a result of exposure to a
traumatic event. In this model, rats are exposed to a severe stressor (15 foot shocks) in one
environment (Context A) and then subsequently exposed to a milder form of the same stressor
(single foot shock) in a different environment (Context B). Animals that did not receive prior
shock treatment exhibit fear responsiveness to Context B in line with the severity of the single
shock given in this context. Animals that had received prior shock treatment in Context A exhibit
an exaggerated learned fear response to Context B. Furthermore, animals receiving a single dose
of morphine immediately following the severe stressor in Context A continue to show an
enhanced fear response in Context B. However, animals receiving repeated morphine
administration (three injections) after exposure to the severe stressor in Context A or a single
dose of morphine at 48 h after the severe stressor no longer exhibit an enhancement in fear
learning to Context B. These results are consistent with clinical studies suggesting that morphine
treatment following a severe stressor may be useful in preventing or reducing the severity of
PTSD in at-risk populations.
Highlights

► We utilize the stress-enhanced fear learning (SEFL) model of PTSD. ► Repeated morphine
administration following trauma blocks SEFL ► Single morphine injection given immediately
following trauma has no effect on SEFL. ► A single morphine injection given 48-hours after the
trauma block SEFL ► Morphine may be an effective preventative therapy for populations at-risk
for PTSD.

Previous article
Next article
Keywords
Morphine
Post-traumatic stress disorder
Stress-enhanced fear learning
Fear conditioning
Foot shock
1. Introduction

Severe and chronic stress induces a myriad of health complications and negatively affects an
individual's physiological and psychological well-being. Traumatic events, physical or
psychological, impact the individual and can induce relatively permanent alterations in the way
the brain processes future events. This change may take a maladaptive form that impairs the
normal functioning of the individual (Christopher, 2004). One of the most severe disorders of the
stress response is post-traumatic stress disorder (PTSD), a chronic and debilitating anxiety
disorder characterized by exaggerated fear or anxiety that develops when the normal fear

response to a traumatic event does not subside over time and begins to interfere with the
individual's daily functioning (Rosen and Schulkin, 1998). At-risk populations include active
military personnel, emergency responders, cancer patients, victims of natural disasters or
accidents and abused children. For example, first-responders to the attacks on the World Trade
Center in 2001 reported a high prevalence of PTSD based on DSM-IV criteria (Bowler et al.,
2010). In addition, a 2010 study by Thomas et al. demonstrated that soldiers having faced
combat in Iraq reported rates of PTSD between 20.7% (at 3-months post-deployment) and 30.5%
(12-months post-deployment). Given these astonishing statistics, it is imperative to investigate
potential preventative measures against the development of PTSD and other anxiety and stress
disorders of similar etiology.

While there have been a number of advancements in the treatment of PTSD, potential
preventative measures remain a highly sought after clinical tool (Shalev, 2009). There is
currently limited evidence to suggest the success of preventative drug therapies. However, recent
new evidence has indicated that morphine treatment following a traumatic event reduces the risk
of developing PTSD and the severity of symptoms in those who do develop the disorder (Bryant
et al., 2009, Holbrook et al., 2010, Nixon et al., 2010, Stoddard et al., 2009). More specifically,
Holbrook and colleagues recently published in the New England Journal of Medicine, an
analysis of clinical data from the Navy–Marine Corps CTR EMED suggesting that the use of
morphine in US military personnel after combat injury reduced the risk of subsequent PTSD
development (Holbrook et al., 2010). Morphine has also been suggested to reduce the
development of PTSD in children who experience a single traumatic event (Nixon et al., 2010).
In fact, the relationship between morphine and PTSD has even been extended to very young

children, ages 1 to 4 years old, admitted to a pediatric burn center with acute burns (Stoddard et
al., 2009). This study showed a correlation between morphine administration and a decrease in
posttraumatic symptoms assessed 3 to 6 months after the burn event. It has been suggested from
these correlational studies that the pharmacotherapeutic use of morphine following a traumatic
event may impede the memory consolidation and associated fear learning that are necessary for
the development of PTSD. These clinical studies suggest that one potential preventative therapy
for PTSD might be the administration of opiates following exposure to the traumatic event,
however, the clinical situation is complex and it is difficult to claim direct causal relationship
between morphine and the behavioral outcome. In this case, animal models of PTSD provide an
opportunity to investigate the hypothesis that morphine administration following a traumatic
event can alter the course of the development of PTSD.

Several animal models of PTSD have been developed, including such models as single
prolonged stress (Yamamoto et al., 2009), inescapable shock (van der Kolk, 1987), predator
exposure and swim stress. While there is no single universally accepted animal model of PTSD,
one excellent model that captures the critical aspect of enhancement in future fear learning
situations is the stress-enhanced fear learning (SEFL) paradigm developed by Fanselow and
colleagues (Rau et al., 2005, Rau et al., 2009). This model involves a procedure in which rats are
exposed to a severe stressor (15 foot shocks) in one environment (Context A) and then
subsequently exposed to a milder form of the same stressor (single foot shock) in a different
environment (Context B). Animals that do not receive the initial stressor (15 foot shocks) exhibit
fear learning to Context B proportional to the administration of the single shock. In these
experiments, fear learning is measured as the degree of freezing behavior displayed during the

time spent in the specific context. The rats receiving the prior shocks in Context A show
enhanced fear learning to Context B where the single shock was presented, i.e., these animals
show freezing behavior that is greater than that which would be expected following exposure to
the single shock that was received in this context. This stress-enhanced fear learning closely
mimics the sensitized reactions to environmental events characteristic of individuals with PTSD.
Moreover, the model shares other characteristics with PTSD such as individual differences in
susceptibility, the finding that amnesia for the traumatic event does not preclude the development
of SEFL, and resistance to extinction trials after the immediate trauma (Rau et al., 2005).

The present study is the first to test the hypothesis that morphine administration following a
severe stressor blocks the development of stress-enhanced fear learning. Rats were exposed to 15
shocks in Context A and later received a single shock in Context B. Animals that were exposed
to Context A but not shocked in that context exhibited conditioned fear to Context B
proportional to the administration of the single shock. In line with previous experiments, animals
receiving prior shock treatment in Context A (15 shocks) showed an exaggerated fear response to
Context B. The effect of morphine was tested in animals that received three injections of
morphine beginning immediately following removal from the severe stressor in Context A and
again at 24 and 48 h post-Context A treatment. In a subsequent experiment, animals received a
single injection of morphine either immediately or 48 h post-Context A treatment.
2. Materials and methods
2.1. Animals

Male Sprague–Dawley rats (250–400 g in weight, Charles-River Laboratories, Raleigh, NC)
were housed individually in a colony room under a reversed day–night (12-hour) cycle. The rats
received free access to food and water throughout the experiment and during at least a one-week
acclimation period prior to experimentation, where the rats were handled semi-daily. All
manipulations were initiated 1 h into the dark phase of the day–night cycle. All procedures were
conducted in accordance with and approval by the UNC Institutional Animal Care and Use
Committee.
2.2. Stress-enhanced fear conditioning procedure

The current experiments utilized the stress-enhanced fear learning (SEFL) model originally
developed by Michael Fanselow and colleagues (Rau et al., 2005; Rau et al., 2009). The SEFL
paradigm employs two distinct contexts, referred to as Context A and Context B. For our studies,
Context A was a standard rodent chamber (BRS/LVE, Laurel, MD; 26.7 × 24.8 × 30.7) housed
in a metal sound attenuating cubicle (BRS/LVE, Laurel, MD) in a quiet room separate from the
animal colony. The chamber has a 16 bar grid floor design (.48 cm in diameter spaced 1.8 cm
apart), smooth metal side walls, and clear plastic front and rear walls, the interior lights were
kept off, and cedar bedding and vanilla extract were used in the chambers to create a distinct
environment from Context B and the home cages. Grid floors were wired to a BRS/LVE shock
generator (SG903) and scrambler (SC922). Context B was a standard rodent chamber (Med
Associates, St. Albans, VT) housed in a wooden sound attenuating cubicle (Med Associates, St.
Albans, VT; 20.5 × 23.5 × 30.7) in a room separate from the one housing Context A and the
animal colony. White noise was provided as background sound in the room. The chamber has a
19 bar grid floor design (.48 cm in diameter spaced 1.6 cm apart), textured, beige, and rubber

lined walls with a clear plastic front wall, the interior lights were kept on, and corn cob bedding
and peppermint extract were used in the chambers to create a distinct environment from Context
A and the home cages. Grid floors were wired to a Med Associates shock generator and
scrambler (ENV-414). Context B was set-up to record the animal's behavior using a video
recording system (Sony Video Camera Model HDR-CX150) directed at the clear front wall of
the chamber.

The experimental design is summarized in Table 1. On Day 1, animals were placed into Context
A for 90 min and received 15 foot shocks (1 mA, 1 s) on a 6-minute variable interval schedule
with the first interval beginning 5 min into the session. Non-shock control animals were exposed
to Context A for an equivalent amount of time, without shocks being delivered. After the session,
animals were returned to their home cages. Animals were given 6 days before the second stage
of the SEFL paradigm. On Day 7, animals were placed into Context B for 30 min to allow for
habituation to the novel context and to test for any generalization between Contexts A and B. On
Day 8, each animal was placed into Context B for 3 min 12 s before receiving a single shock (1
mA, 1 s). Baseline level of freezing was determined during the period before the delivery of the
shock in Context B. Animals were removed from Context B at 3 min 44 s and returned to their
home cage. On Days 9, 10, 15 and 23 (test days 1, 2, 7, and 14 post-Context B conditioning,
respectively), animals were tested in Context B for the assessment of freezing behavior, a
behavioral quantification of learned fear, during an 8 min 32 s session (no shocks administered).
Freezing behavior was measured as the time spent immobile, except for movement necessary for
respiration, during the 8 min 32 s spent in Context B on test day (Rau et al., 2005). The complete

session recording was analyzed by raters blind to the treatment condition. The rating procedure
was shown to have high inter-rater reliability.
Table 1. Experimental design.
Days 9, 10,
Day 1

Day 7

Day 8

15, 23

(severe stressor)

(habituation)

(mild stressor)

(test days 1,
2, 7, 14)

Group 1

Context A 15 shocks

Context B 3 min 44 s with
Context B

(severe

(1 mA, 1 s) over

Context B
1 shock (1 mA, 1 s) at

30 min
stressor)

90 min

8 min 32 s
3 min 12 s
Context B 3 min 44 s with

Group 2 (no-

Context B
Context A 90 min

severe stressor)

Context B
1 shock (1 mA, 1 s) at

30 min

8 min 32 s
3 min 12 s

2.3. Pharmacological manipulations

Morphine was obtained from the National Institute on Drug Abuse (NIDA). For the initial test,
animals in separate groups were treated with morphine dissolved in saline (7.5 mg/kg,
subcutaneously) or saline immediately after the 90 min session in Context A (shocked or nonshocked) and additionally 24 and 48 h after the session. In the subsequent test, morphine (15
mg/kg, subcutaneously) or saline was given as a single injection either immediately or 48 h after
the 90 min session in Context A. Thus, the design of each study included groups that received
shock or no shock in Context A and were treated with either morphine or saline.

2.4. Statistical analysis

Percent freezing in Context B was determined for the time period prior to the single shock
experience in the context (baseline) and subsequently during each of the four test sessions. The
effect of Context A treatment (shock or no shock) and morphine or saline administration on
baseline freezing in Context B prior to the shock was analyzed for statistical significance using a
standard 2 × 2 analysis of variance (ANOVA). Percent freezing during the test sessions was
analyzed using a 2 × 2 × 4 repeated measures ANOVA with test day (Days 1, 2, 7 and 14) as the
repeated measure and Context A treatment (shock or no shock) and drug treatment (morphine or
saline) as between-subject variables. For all experiments, the significance level was set at.05.
Significant interactions were examined using Tukey's post-hoc comparisons.
3. Results
3.1. Stress-enhanced fear learning

Fig. 1 shows the establishment of the stress-enhanced fear learning (SEFL) model using the
specified parameters and without any injections. The results show a significant main effect of
shock in Context A on conditioned freezing in Context B, F(1, 10) = 8.80, p < .05, indicating that
the prior administration of shock in Context A enhanced fear learning to a single shock
experience in Context B. There was also a significant main effect across test days, F(3, 30) =
12.36, p < .01, with a significant linear component, F(1, 30) = 15.53, p < .01, indicating that
conditioned fear diminished over the test days. There was no significant interaction of the prior
shock experience with the test days indicating a consistent effect of prior shock in Context A
across the test days. There were also no significant differences in baseline freezing in Context B

prior to the shock. Thus, there was a pronounced SEFL using the specified apparatus and
parameters that remains robust across multiple test days.

Fig. 1. Shows the establishment of the stress-enhanced fear learning (SEFL) model. There were
no significant differences in baseline level of freezing, determined during the period before the
delivery of the shock in Context B. The animals that received shock in Context A (solid circle)
exhibited a significant increase in conditioned freezing in Context B compared to the group that
did not receive prior shock treatment (open circle) (n = 6). Thus, there was a pronounced SEFL
using the specified apparatus and parameters.
3.2. Effects of multiple injections of morphine after the shock in Context A

Fig. 2 shows the effect of morphine (7.5 mg/kg) administered immediately after the Context A
experience and again 24 and 48 h later. The results showed no significant effects on baseline
freezing in Context B determined prior to the shock in that context. In contrast, the results
showed a significant effect of shock in Context A on conditioned freezing in Context B, F(1, 20)
= 12.66, p < .01, indicating that the prior administration of shock enhanced fear learning to a
single shock experience in Context B. There was also a significant effect across test days, F(3,
60) = 50.82, p < .01, with a significant linear component, F(1, 60) = 115.67, p < .01 indicating
that conditioned fear diminished over the test days. Most importantly, there was a significant
interaction between the shock experience in Context A and the morphine injections, F(1, 20) =
7.91, p < .05. Tukey's post-hoc comparisons of the four groups showed that between the two

saline-treated groups, the group shocked in Context A (M = 58.54, 95% CI [39.5, 77.58])
exhibited a significantly higher percentage of freezing behavior to Context B than the group that
did not receive prior shock treatment (M = 20.12, 95% CI [3.0, 37.16]) indicating a significant
SEFL effect. Most notably, the group receiving repeated morphine treatment that had been
exposed to the severe stressor (15 shocks) in Context A was not significantly different from the
non-shocked, saline-treated group. Thus, there was a pronounced SEFL effect that was prevented
by the series of morphine injections following shock in Context A.

Fig. 2. Shows the effect of repeated morphine (7.5 mg/kg; 0, 24 and 48 h post-shock treatment in
Context A) administration on conditioned freezing behavior in Context B. There were no
significant differences in baseline level of freezing, determined during the period before the
delivery of the shock in Context B. Within the saline-treated groups, the animals that received
the severe stressor (15 shocks) in Context A (solid circle) exhibited a significant increase in
conditioned freezing in Context B compared to the animals that did not receive prior shock
treatment (open circle). There was no effect of morphine on freezing in Context B for the
animals that did not receive prior shock treatment (open square). Most importantly, the group
shocked in Context A that then received repeated morphine treatment (closed square) did not
show significant SEFL (n = 6). Thus, the pronounced SEFL was prevented by the series of
morphine injections following the shock in Context A.
3.3. Effects of injection of a single morphine injection immediately after shock in Context A

Fig. 3A shows that morphine (15 mg/kg) administered immediately after the Context A
experience had no significant effect. The analysis showed no significant effects on baseline
freezing in Context B prior to the shock in that context. In contrast, the results show a significant
main effect of shock in Context A on conditioned freezing in Context B, F(1, 19) = 4.59, p < .05,
indicating that the prior administration of shock enhanced fear learning to the single shock
experience in Context B. There was no significant main effect of drug. There was a significant
main effect of test days, F(3, 57) = 41.02, p < .01, with a significant linear component, F(1, 57) =
71.81, p < .01, indicating that conditioned fear diminished over the test days. There was no
significant interaction between the prior shock experience and test day. Interestingly, there was
no significant interaction between the shock experience in Context A and the morphine
injections. Thus, morphine administration immediately after the Context A shock experience had
no significant effect on the development of SEFL.

Fig. 3. Shows the effect of morphine (15 mg/kg) administered immediately after the Context A
experience (A) or 48 h later (B). For both A and B the animals that received shock in Context A
followed by treatment with saline (solid circle) showed a significant increase in conditioned
freezing in Context B compared to the group that received saline but did not receive prior shock
treatment (open circle). Morphine administration did not alter conditioning in Context B for the
group that did not receive prior shock treatment in Context A (open square). Interestingly, the
group that received morphine treatment immediately after the severe stressor in Context A
(closed square) continued to exhibit significant SEFL (A). In contrast, the group shocked in

Context A that received morphine treatment (closed square) 48 h later did not show significant
SEFL (B). There were no significant differences in baseline level of freezing which was
determined during the period before the delivery of the shock in Context B (n = 5–6). Thus, the
pronounced SEFL was prevented by a single injection of morphine 48 h following the shock in
Context A, but not when it was administered immediately after the severe stressor.
3.4. Effects of a single morphine injection 48 h after shock in Context A

Fig. 3B shows the effect of morphine (15 mg/kg) administered 48 h after the Context A
experience. The results showed no significant effects on baseline freezing in Context B prior to
the shock in that context. As in the previous experiments, the results showed a significant effect
of shock in Context A on conditioned freezing in Context B, F(1, 18) = 21.36, p < .01, indicating
that the prior administration of shock enhanced fear learning to a single shock experience in
Context B. There was also a significant effect across test days, F(3, 54) = 45.98, p < .01, with a
significant linear component, F(1, 54) = 104.99, p < .01, indicating that conditioned fear
diminished over the test days but did not interact with the prior shock experience. Most
importantly, there was a significant interaction between the shock experience in Context A and
the morphine injection, F(1, 18) = 4.57, p < .05. Tukey's post-hoc comparisons of the four groups
indicated that between the two saline-treated groups, the group receiving shock in Context A (M
= 42.77, 95% CI [22.92, 62.62]) showed a significantly higher percentage of freezing in
comparison to the group that was not shocked in Context A (M = 6.14, 95% CI [1.88, 10.41])
indicating a significant SEFL effect. No other statistically significant differences were found.
Most notably, the group receiving a single dose of morphine at 48 h post-stressor (15 shocks in
Context A) was not significantly different from the non-shocked, saline-treated group. Thus,

there was a pronounced SEFL that was attenuated by the injection of morphine 48 h following
the shock in Context A.
4. Discussion

Recent clinical data has indicated that morphine treatment following a traumatic event may
reduce the risk of developing PTSD and the severity of symptoms in those who develop the
disorder (Bryant et al., 2009, Holbrook et al., 2010, Nixon et al., 2010, Stoddard et al., 2009).
From these clinical correlational studies, it has been suggested that morphine administration
following a trauma interrupts the memory consolidation that is necessary for the development of
PTSD. In the current study, rats were subjected to the stress-enhanced fear learning (SEFL)
paradigm in which they received a severe stressor (15 shocks) in Context A followed by a milder
form of the same stressor in Context B (1 shock). Results from the first experiment indicate that
animals that had received the severe stressor in Context A exhibit an increase in freezing
behavior in Context B that is disproportionate to the single shock received there. This
enhancement in fearful behavior is similar to that observed in previous studies and has been
postulated to result from a sensitization to fearful stimuli and an enhancement of subsequent fear
learning (Rau et al., 2005, Rau and Fanselow, 2009). This model suggests that there is an
alteration in the processing of fearful stimuli following exposure to the severe stressor that
manifests as an enhancement of future fear learning and indicates that SEFL closely mimics
certain aspects of the human condition of PTSD.

This study investigated the effect of morphine administration on the expression of SEFL.
Repeated morphine administration (7.5 mg/kg; 0, 24, 48 h post-Context A) resulted in a

significant reduction in freezing behavior and thus, an attenuation of the enhanced fear learning
that is the hallmark of this animal model. Interestingly, administration of a single dose of
morphine (15 mg/kg) had a time-dependent effect on the expression of SEFL. A single dose of
morphine administered immediately after the severe stressor in Context A did not reduce the
exaggerated fear response in Context B. However, a single dose of morphine 48 h after the
severe stressor in Context A attenuated the exaggerated fear response in Context B. These results
raise several interesting points. First, prior research has shown that increasing doses of the
anesthetic isoflurane administered during the shock treatment in Context A will reduce SEFL
behavior in Context B (Rau et al., 2009). In the present experiments, the fact that there is no
effect of morphine when the drug is administered immediately following the severe stressor
would likely rule out the possibility that the effect of morphine on SEFL is due simply to a
decrease in the pain experience since the analgesic effects of the drug would be most potent
when given immediately after the repeated shocks in Context A. Furthermore, there is no effect
of morphine on fear learning to Context B in control animals that did not receive severe shock in
Context A indicating that morphine itself did not alter the pain perception of the subsequent
single shock in Context B.

Interestingly, the finding that a single dose of morphine reduces SEFL when administered 48 h
after the severe stressor suggests that morphine's mechanism of action is related to consolidation
processes that are occurring around that time point as morphine has a half-life of approximately
2–4 h. Related results have been found in other studies utilizing animal models of PTSD. For
example, Kozlovsky et al. (2012) demonstrated that administration of a CRH-R1 antisense
oligodeoxynucleotide into the hippocampus 48 h after exposure to a predator scent stress

paradigm results in decreased anxiety indices and increased BDNF and pERK1/2 levels. CRHR1 antisense administration at 1 h after the stressor had no effect. These results suggest that 48 h
post-stressor is a critical time point in the modulation of HPA axis activity and the HPA axis is
one pathway through which morphine may exert its effects on SEFL expression. Another method
by which morphine may alter SEFL is by disrupting the consolidation of fear memories.
Memories associated with traumatic experiences appear to undergo a systems consolidation
process such that the memory is localized to different brain regions at different times following
the event. Protein kinase M zeta PKM ζ is a protein kinase that has been shown to be involved
in both long-term potentiation (LTP) and memory storage processes (Ling et al., 2002, Sacktor et
al., 1993). Dorsal hippocampal (DH) inactivation of PKMζ 1

h after exposure to predator scent

stress reduced both anxiety and responsiveness to a cue of the trauma given 8 days later (Cohen
et al., 2010). Conversely, PKMζ inactivation within the insular cortex 10 days after the trauma
was also able to reduce these PTSD-like symptoms. However, inactivation of DH PKMζ
days or IC PKMζ

at 10

inactivation at 1 h post-stressor had no effect suggesting that the storage of

the memory was moved over time.

Prior work has shown that pharmacological amnesic agents do not induce an attenuation of SEFL
(Rau et al., 2005) suggesting that memory of the traumatic event is not central to the
development of SEFL. Rather, it seems that there is an alteration in the threshold for learning
regarding future fearful stimuli such that mildly aversive stimuli become capable of producing
exaggerated fear responses. This change in behavior may be expressed due to plasticity of the
neural circuitry underlying fear learning. The hippocampus plays a critical role in mediating
learning and memory, in general, and has recently been shown to be an important neural

substrate for learning regarding fearful or anxiety-provoking stimuli. It is widely recognized that
damage to the human hippocampal formation results in an amnesic syndrome (e.g., Nadel and
Moscovitch, 1997). Furthermore, many studies in animals have examined the effects of
hippocampal lesions on learning and memory processes including contextual fear acquisition
(e.g., Phillips and LeDoux, 1992). Although the effects of hippocampal lesions are complicated
and the interpretation of the effects is intensely debated in recent years, there is overwhelming
evidence that the hippocampal formation plays a critical role in contextual fear conditioning
(e.g., Anagnostaras et al., 2001, Bannerman et al., 2004). At the heart of this debate is the
postulation of unique roles of the dorsal and ventral hippocampus in fear conditioning and
memory. For example, lesion studies in rats have suggested that the dorsal hippocampus is
especially important in the acquisition of contextual fear (e.g., Bannerman et al., 2004), but there
is some evidence suggesting it is primarily responsible for encoding spatial learning (see
Bannerman et al., 2004). In contrast, the ventral hippocampus may have a preferential role in
brain processes associated with anxiety related behaviors. Interestingly, mice with lesions to the
dorsal hippocampus, while still capable of acquiring contextual fear learning, exhibit a rapid
decline in the ability to recall fear memories at future time points (Zelikowsky et al., 2012).

Given the above findings, it is unclear as to the specific targets on which morphine might be
exerting its effects; however, previous research has shown a role for opioid receptors in both fear
and contextual learning paradigms. For example, deletion of the mu-opioid receptor results in
impaired acquisition of fear learning in mice (Sanders et al., 2005) and an injection of morphine
into the either the amygdala or the hippocampus results in impairment of contextual fear
conditioning (Westbrook et al., 1997). More specifically, the intercalated nucleus (ICN) of the

amygdala has recently been postulated to contribute to fear extinction via its inhibitory actions
on the output capacity of the central nucleus of the amygdala (Pare and Smith, 1993). The
neurons in the ICN display mu-opioid receptors, the activation of which may lend to the
modulation of communication between the basolateral and central amygdalar regions and
inhibition of behavioral fear responses (Poulin et al., 2006). In addition, recent studies have
found that cytokines, historically viewed as immune molecules, are not only present in the brain
but may play important roles in processes such as learning and memory. For example, the
cytokine interleukin-1β (IL-1β) has been shown to be involved in learning and memory, and is
altered in response to stressful stimuli. Acute stress increases IL-1β reactivity in astroglia in the
hippocampus, amygdala, hypothalamus and PAG (Sugama et al., 2011). Interestingly, evidence
suggests that, under some circumstances, IL-1β is required for the normal physiological
regulation of hippocampal function and memory processing as it has been shown that the
absence of IL-1β impairs memory consolidation and the targeted deletion of IL-1β in animal
studies leads to severely impaired hippocampal dependent memory (Goshen et al., 2007,
Pickering and O'Connor, 2007). Mice with targeted deletion of the IL-1 receptors display a
severely impaired hippocampal dependent but normal hippocampal independent memory.
Furthermore, these mice demonstrate diminished short-term plasticity and exhibit no long-term
potentiation (Avital et al., 2003). There is also evidence for the role of IL-1β in the consolidation
of memories that involved contextual fear which is dependent upon hippocampal function (e.g.
Pugh et al., 2001). In contrast, the injection of pathophysiological levels of IL-1β can produce
detrimental effects on memory. These detrimental effects of high levels of IL-1β are also specific
for the consolidation of memory that depend on the hippocampus, whereas hippocampal
independent memories are not altered by high levels of IL-1β (Goshen et al., 2007, Goshen and

Yirmiya, 2009, Pugh et al., 2001). Thus, although the effects are complex and may depend on
factors such as the magnitude and timing of IL-1β expression, there is now substantial evidence
indicating that IL-1β is a critical element in behavioral outcomes such as the learning of fear
responses and the potential long-term consequences of that form of learning. Furthermore,
morphine has been shown to reduce the expression of hippocampal IL-1β (Patel et al., 1996)
suggesting that IL-1 β may be a potential mechanism through which morphine is acting to block
SEFL.
5. Conclusion

Post-traumatic stress disorder (PTSD) is commonly defined as a severe and chronic anxiety
disorder that results when the normal fear response to a traumatic event does not subside over
time and begins to interfere with the individual's daily functioning (Rosen and Schulkin, 1998).
Aside from its psychological symptoms, PTSD patients may also display increased susceptibility
to drug addictions (Barsy et al., 2011), altered glucose metabolism and inflammation associated
with type 2 diabetes (Nowotny et al., 2010), imbalances in T-cell distribution and proliferation
indicative of compromised immune functioning (Sommershof et al., 2009) and increased risk of
cardiovascular disease (Kibler, 2009). Currently, there is little knowledge about how PTSD
formation can be prevented in the aftermath of a major stress or trauma, but there is emerging
research focusing on the potential of opioid pharmacotherapy in the prevention of this
devastating disorder. The present research provides support for the effectiveness of opioid
pharmacotherapy in the suppression of SEFL and has the promise to provide critical insights into
the neural mechanisms and potential new treatments for PTSD.
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